Our Initiatives


Low Dose Naltrexone (LDN), a breakthrough treatment for chronic and autoimmune diseases, is helping over 300,000 patients worldwide. LDNscience, by MedInsight, is the most authoritative and up-to date source of information about LDN, housing the entire collection of research and scientific studies, interviews with scientists, physicians and patients, a free global LDN prescriber directory, and frequently asked questions.

read more

eye dipyridamole

Dipyridamole, a cardiovascular drug in use for over 50 years, has been rediscovered as a powerful treatment for a number of difficult-to-treat eye disorders. EyeDipyridamole.org, by MedInsight, is the up-to date source of information about dipyridamole for eye disorders. It houses all the research and scientific studies, interviews with researchers and patients, frequently asked questions and the latest news about this novel eye treatment.

read more


Cureiosity® is a repository of manually curated knowledge about novel treatments for serious, chronic, and intractable diseases. The knowledge is created by data-scientists who analyze the global medical literature, and catalogue the information they extract in a proprietary manner using a next-generation graph-database. Cureiosity places patients’ interest first by focusing on overlooked treatments that don’t benefit from commercial sponsorship.

read more